Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - Other
Ratios

Akebia Therapeutics (AKBA) Long-Term Debt Issuances (2024 - 2025)

Akebia Therapeutics (AKBA) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $10.0 million as the latest value for Q1 2025.

  • Quarterly Long-Term Debt Issuances fell 72.97% to $10.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $10.0 million through Dec 2025, down 77.78% year-over-year, with the annual reading at $10.0 million for FY2025, 77.78% down from the prior year.
  • Long-Term Debt Issuances for Q1 2025 was $10.0 million at Akebia Therapeutics, up from $8.0 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $37.0 million in Q1 2024, with the low at $8.0 million in Q2 2024.